In this Q&A, Ping Liu, PhD, and Pietro Ravani, MD, PhD, answer our questions about the diagnosis and management of chronic kidney disease and discuss how the current definition of CKD does not consider age-related kidney function decline.
A research team recently investigated whether high-dose corticosteroid therapy impacts bone turnover markers to a greater extent than low-dose corticosteroid therapy. Lead researcher Pradeesh Sivapalan, MD, PhD, answered our questions about this study.
A recent review suggests that NSAIDs are just as effective as opioids for treating acute musculoskeletal injuries such as sprains and strains, yet they have a lower potential for harm. Lead author Jason Busse, DC, PhD, answered our questions about this review.
In this Q&A, Edward Kuan, MD, answers our questions about nasal polyps, including their clinical characteristics, prevalence, surgery recommendations, and recurrence rates.
W. Benjamin Nowell, PhD, and Kelly Gavigan, MPH, on Barriers to Optimizing Rheumatoid Arthritis Treatment, Achieving Patients' Goals
A new analysis of the ArthritisPower registry aimed to identify factors that patients believe influenced their physician’s treatment decisions. Lead authors W. Benjamin Nowell, PhD, and Kelly Gavigan, MPH, answered our questions.
Dr Michels shared important findings and implications from her new study on whether metabolic syndrome is associated with ovarian cancer risk.
What are the associations between Takotsubo syndrome and cannabis use? In this Q&A, Rupak Desai, MBBS, explains what he and his research team discovered about the relationship and how their results should influence the conversations you have with your patients.
As the number of new hepatitis C virus infections continues to rise in the United States, rapid diagnosis and treatment of high-risk patients is more important than ever. In this Q&A, Benjamin Eckhardt, MD, answered our questions about his study on this topic at IDWeek 2021.
Despite being approved for use by the FDA in 2019, many questions remain on the safety, tolerability, and efficacy of ubrogepant in certain patient populations with migraine in the real-world population. Consultant360 reached out to Chia-Chun Chiang, MD, about her study examining this relationship.
Researchers conducted a study of genomic data to clarify the relationships among nonalcoholic fatty liver disease, type 2 diabetes, and obesity. Lead author Wanqing Liu, PhD, answered our questions about the study.